Post-LASIK patient dissatisfaction

Article

People who are dissatisfied with the results of LASIK are more likely to be referred to a cornea service by their doctor than by their LASIK surgeon.

People who are dissatisfied with the results of LASIK are more likely to be referred to a cornea service by their doctor than by their LASIK surgeon, according to the results of a study published in the January issue of the Journal of Cataract and Refractive Surgery.

Brett Levinson and colleagues from the Wills Eye Institute, Pennsylvania, USA conducted a retrospective chart review of all patients seen for consultation between January 2004 and December 2006, who had had LASIK performed elsewhere.

A total of 157 eyes of 109 patients were included in the study. Twenty-eight percent of subjects were referred by their LASIK surgeon, 54% by another eye doctor and 17% were self-referred. The most common complaints were poor distance vision (63%), dry eye (19%), redness/pain (7%) and glare/halos (5%). Forty-four eyes (28%) had surgical complications or enhancements. The most common diagnoses were dry eye or blepharitis (27.8%), irregular astigmatism (12.1%) and epithelial in-growth (9.1%). Medical management was offered in 39% of cases, surgical intervention in 27% and observation only in 7%. Non-surgical therapy was offered in 73% of cases.

The results of this study demonstrate that poor distance vision, dry eye, redness/pain and glare/halos are the most common reason for a referral to a cornea specialist after LASIK and that patients are more likely to be referred to such a service by a doctor other than their LASIK surgeon.

Recent Videos
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
Paulo Antonio Silva, Associate Professor of Ophthalmology at Harvard Medical School
Intraocular Pressure Outcomes Following Suprachoroidal Triamcinolone Acetonide in Patients With Glaucoma, Ocular Hypertension, or Steroid Response
Durga Borkar, MD, MMCi, discusses FAS inhibition with ONL-1204
Theodore Leng, MD, MS, speaks about 12-Month Real-World Clinical and Anatomical Outcomes With Faricimab in Patients With Diabetic Macular Edema:The FARETINA-DME Study
Rishi P. Singh, MD, discussed his presentation on the results from part 1 of the Phase 2/3 SIGLEC trial assessing AVD-104 for GA
Carl C. Awh, MD, FASRS, speaks with Hattie Hayes of Ophthalmology Times Europe
Carl J. Danzig, MD
Martin Zinkernagel, MD, PhD, speaks about the ASRS sustainability expert panel
Srinivas Sai Kondapalli, MD, discusses outer retinal tubulations in lesion growth for subfoveal and non-subfoveal GA
© 2024 MJH Life Sciences

All rights reserved.